ArticleRegenerative therapy2025
Microbiome-based profiles of airborne bacteria to support microbial risk assessment in cleanroom environments.
Article in Regenerative therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Maintaining aseptic conditions is essential for cell product processing, as sterilization cannot be applied to living cells. Conventional environmental monitoring relies on particle counts and culture-based colony-forming unit measurements. These indicators fail to capture much of the diversity and provenance of airborne microbes because many taxa are nonculturable or require growth conditions not supported by standard culture media. Therefore, comprehensive DNA-based microbiome analysis is critical for evaluating microbial risks that conventional methods may overlook; however, such studies remain limited in cleanroom settings. This study aimed to comprehensively visualize the structure of airborne microbial communities in cleanroom environments and clarify microbial risks that cannot be fully captured by particle counts or culture-based methods. Methods: We collected airborne bacterial DNA from cleanrooms with environmental Grades B, C, and D using a high-volume air sampler. The DNA was extracted and analyzed via 16S rRNA gene amplicon sequencing targeting the V3-V4 regions. Bioinformatic analysis was performed using the QIIME2 pipeline, and microbial diversity was assessed using alpha and beta diversity indices. Abundant taxa were categorized based on their likely origin (environment- or skin-derived), and their distributions were examined in relation to facility management practices. Results: Analysis revealed the consistent detection of skin-associated bacteria, such as Conclusions: This study demonstrates the limitations of conventional culture-based monitoring and underscores the value of DNA-based approaches for characterizing airborne microbial communities in cleanrooms. The detection of temporary increases in skin-associated bacteria indicates that operator-related contamination can occur even under stringent environmental conditions. These findings support the development of integrated monitoring strategies that can capture both the composition and temporal fluctuations of airborne microbiota to enhance microbial risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.